Published in Clin Infect Dis on July 01, 1992
Infections in solid-organ transplant recipients. Clin Microbiol Rev (1997) 2.86
Primary cutaneous aspergillosis in an immunocompetent patient. J Surg Tech Case Rep (2011) 0.92
Cutaneous alternariosis in a liver transplant recipient. Clin Infect Dis (1993) 0.86
Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis (1988) 2.76
Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis (1996) 2.12
Factors related to the development of CMV-specific CD8+ T cell response in CMV-seropositive solid organ transplant candidates. Am J Transplant (2015) 2.08
[Endocarditis caused by non-diphtheriae Corynebacterium. Presentation of 12 cases and review]. Enferm Infecc Microbiol Clin (1993) 2.07
Bier's block--under pressure? Anaesthesia (1997) 2.02
Infections in adult liver transplant patients under FK 506 immunosuppression. Transplant Proc (1991) 1.75
Folic acid use and major congenital malformations in offspring of women with epilepsy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry (2008) 1.67
Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation. Transplantation (1995) 1.59
Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am J Transplant (2006) 1.55
Variation in antifungal prophylaxis strategies in lung transplantation. Transpl Infect Dis (2006) 1.52
Assessing bedside cardiologic examination skills using "Harvey," a cardiology patient simulator. Acad Emerg Med (1997) 1.49
Daptomycin is safe and effective for the treatment of gram-positive cocci infections in solid organ transplantation. Transpl Infect Dis (2014) 1.41
Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion. Eur J Clin Microbiol Infect Dis (2001) 1.39
Infections with FK 506 immunosuppression: preliminary results with primary therapy. Transplant Proc (1990) 1.30
De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl (2001) 1.30
Epidemiology of legionella pneumonia and factors associated with legionella-related mortality at a tertiary care center. Clin Infect Dis (1998) 1.28
Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease. J Infect Dis (1997) 1.23
Outcome of HCV/HIV-coinfected liver transplant recipients: a prospective and multicenter cohort study. Am J Transplant (2012) 1.22
Constitutively vancomycin-resistant Enterococcus faecium resistant to synergistic beta-lactam combinations. Antimicrob Agents Chemother (1993) 1.18
Time to detection of cytomegalovirus (CMV) DNA in blood leukocytes is a predictor for the development of CMV disease in CMV-seronegative recipients of allografts from CMV-seropositive donors following liver transplantation. J Infect Dis (1996) 1.15
Human cerebral gliomas: correlation of postmortem MR imaging and neuropathologic findings. Radiology (1989) 1.14
Cryptococcal meningitis: an analysis among 5,521 consecutive organ transplant recipients. Transpl Infect Dis (2002) 1.14
Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation. J Infect Dis (1992) 1.12
Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study. Clin Infect Dis (2005) 1.11
Successful long-term treatment with linezolid for disseminated infection with multiresistant Nocardia farcinica. Infection (2008) 1.09
Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA. Transplantation (1997) 1.08
Cryptococcal meningitis after liver transplantation. Transplantation (1996) 1.08
CNS aspergillosis in organ transplantation: a clinicopathological study. J Neurol Neurosurg Psychiatry (1993) 1.07
Epidemiology of invasive fungal infection. Int J Antimicrob Agents (2008) 1.07
Cytomegalovirus disease in intestinal transplantation. Transplant Proc (1995) 1.07
Brain abscess in solid organ transplant recipients receiving cyclosporine-based immunosuppression. Arch Surg (1997) 1.05
The spectrum of aspergillosis in liver transplant patients: comparison of FK 506 and cyclosporine immunosuppression. Transplant Proc (1991) 1.05
Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain. Clin Microbiol Infect (2010) 1.04
Transmission of infection with herpes simplex virus by renal transplantation. J Infect Dis (1987) 1.03
The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses. Clin Infect Dis (1995) 1.03
Guidance of ganciclovir therapy with pp65 antigenemia in cytomegalovirus-free recipients of livers from seropositive donors. Transplantation (1996) 1.02
The effect of cyclosporine on exocrine function of the rat pancreas--an in vitro study. Transplantation (1991) 1.01
Immunosuppressive therapy and infection after kidney transplantation. Transpl Infect Dis (2010) 1.01
Evidence of a direct TRH effect on the rat exocrine pancreas. Rev Esp Fisiol (1991) 0.99
Successful therapy for cerebral phaeohyphomycosis due to Dactylaria gallopava in a liver transplant recipient. Clin Infect Dis (1994) 0.99
The radiology of pulmonary cryptococcosis in a tertiary medical center. J Thorac Imaging (2001) 0.98
Impact of OKT3 Therapy on Cytomegalovirus and Herpes Simplex Virus Infections After Liver Transplantation. Transplant Proc (1988) 0.97
Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients. Ann Surg (1996) 0.96
The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation. Transplantation (1993) 0.95
Deafness and blindness in a HIV-positive patient with cryptococcal meningitis. Postgrad Med J (1996) 0.95
Self-limited Toxoplasma parasitemia after liver transplantation. Transplantation (1987) 0.94
Factors associated with recurrent cytomegalovirus disease after small bowel transplantation. Transplant Proc (1994) 0.94
Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis. Clin Infect Dis (1997) 0.94
Acute invasive sinusitis due to Trichoderma longibrachiatum in a liver and small bowel transplant recipient. Clin Infect Dis (1998) 0.93
The clinical epidemiology of pulmonary cryptococcosis in non-AIDS patients at a tertiary care medical center. Medicine (Baltimore) (2001) 0.93
A prospective randomized trial comparing sequential ganciclovir-high dose acyclovir to high dose acyclovir for prevention of cytomegalovirus disease in adult liver transplant recipients. Transplantation (1994) 0.93
Pneumonia after heart transplantation: a multi-institutional study. Spanish Transplantation Infection Study Group. Clin Infect Dis (1998) 0.92
Leishmania esophagitis in an AIDS patient: an unusual form of visceral leishmaniasis. Am J Gastroenterol (1994) 0.92
Primary systemic amyloidosis causing diffuse alopecia by telogen arrest. Arch Dermatol (1991) 0.92
Clostridium innocuum bacteremia secondary to infected hematoma with gas formation in a kidney transplant recipient. Transpl Infect Dis (2003) 0.91
Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort. Transpl Infect Dis (2012) 0.91
Temporary withdrawal of immunosuppression for life-threatening infections after liver transplantation. Transplantation (1994) 0.91
Sebaceous adenoma with a cutaneous horn. J Cutan Pathol (1995) 0.90
Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations. J Viral Hepat (2004) 0.90
Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: data from the RESITRA study group. Am J Transplant (2007) 0.90
Pulmonary zygomycosis in solid organ transplant recipients in the current era. Am J Transplant (2009) 0.89
Tuberculosis of the tongue in two immunocompetent patients. Clin Infect Dis (1994) 0.89
The epidemiology of parainfluenza virus infection in lung transplant recipients. Clin Infect Dis (2001) 0.88
Relapsing bacteremia in patients with ventricular assist device: an emergent complication of extended circulatory support. Ann Thorac Surg (2001) 0.88
Cutaneous legionellosis: case report and review of the medical literature. Transpl Infect Dis (2014) 0.87
Prospective evaluation of fever of unknown origin in patients infected with the human immunodeficiency virus. Grupo Andaluz para el Estudio de las Enfermedades Infecciosas. Eur J Clin Microbiol Infect Dis (1996) 0.87
Fluconazole therapy in transplant recipients receiving FK506. Transplantation (1994) 0.86
Predictive factors for early mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother (2013) 0.86
Acute respiratory failure associated with pulmonary cryptococcosis in non-aids patients. Chest (2001) 0.86
Efficacy of liposomal amphotericin B in the treatment of visceral leishmaniasis in patients coinfected with the human immunodeficiency virus. Clin Infect Dis (1995) 0.86
Diagnosis of cytomegalovirus infections by shell vial assay and conventional cell culture during antiviral prophylaxis. J Clin Microbiol (1994) 0.85
Efficacy of intermittent liposomal amphotericin B in the treatment of visceral leishmaniasis in patients infected with human immunodeficiency virus. Clin Infect Dis (1995) 0.85
Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome. Transplantation (2000) 0.84
Successful therapy for cerebral phaeohyphomycosis due to Dactylaria gallopava. Clin Infect Dis (1996) 0.84
The influence of HLA donor-recipient compatibility on the recurrence of HBV and HCV hepatitis after liver transplantation. Transplantation (1995) 0.84
Pretransplant interferon-γ secretion by CMV-specific CD8+ T cells informs the risk of CMV replication after transplantation. Am J Transplant (2013) 0.84
The pathogenesis and management of influenza virus infection in organ transplant recipients. Transpl Infect Dis (2002) 0.84
Immunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infection. Eur J Clin Microbiol Infect Dis (2011) 0.84
Candida infections in solid organ transplantation. Am J Transplant (2013) 0.83
Cutaneous T-cell lymphoma of the eyelid in a patient with acquired immunodeficiency syndrome. Cutis (1996) 0.83
The impact of blood transfusion on the occurrence of pneumonitis in primary cytomegalovirus infection after liver transplantation. Transfusion (1993) 0.83
Neuropathologic findings in liver transplantation: a comparative study of cyclosporine and FK 506. Transplant Proc (1991) 0.83
Infectious complications after human small bowel transplantation. Transplant Proc (1992) 0.82
Successful treatment of antimony-resistant cutaneous leishmaniasis with liposomal amphotericin B. Clin Infect Dis (1994) 0.82
Factors associated with the development of post-transplant lymphoproliferative disease (PTLD) in Epstein-Barr virus (EBV)-seronegative adult liver transplant recipients. Transpl Int (1994) 0.82
Incisional surgical infection in heart transplantation. Transpl Infect Dis (2008) 0.80
Influenza A myocarditis developing in an adult liver transplant recipient despite vaccination: a case report and review of the literature. Transplantation (2000) 0.80
Cerebral fungal infections in the immunocompromised host: a literature review and a new pathogen--Chaetomium atrobrunneum: case report. Neurosurgery (1999) 0.80
Concurrent pulmonary Aspergillus fumigatus and mucor infection in a cardiac transplant recipient: a case report. Transplant Proc (2012) 0.79
Association between donor-recipient HLA-DR compatibility and cytomegalovirus hepatitis and chronic rejection in liver transplantation. Transplant Proc (1993) 0.79
Fulminant hepatitis due to human adenovirus. Infection (2013) 0.79
Mycobacterial infections in solid organ transplant recipients. Clin Microbiol Infect (2014) 0.79
Posttransplant B, non-A non-B, and cytomegalovirus hepatitis increase the risk of developing chronic rejection after liver transplantation. Transplant Proc (1995) 0.79
Prevention strategies for cytomegalovirus disease and long-term outcomes in the high-risk transplant patient (D+/R-): experience from the RESITRA-REIPI cohort. Transpl Infect Dis (2014) 0.79